David C. Hornigold

Robust anti‐obesity and metabolic effects of a dual <scp>GLP</scp> ‐1/glucagon receptor peptide agonist in rodents and non‐human primates

Susan Henderson, Anish Konkar, David C. Hornigold et al. · Diabetes Obesity and Metabolism · 2016 · 235 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery

Pierre Larraufie, Geoffrey Roberts, Anne K. McGavigan et al. · Cell Reports · 2019 · 165 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

Victoria E R Parker, Darren Robertson, Tao Wang et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 117 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

M. Pilar Valdecantos, Virginia Pardo, Laura Ruíz-Cañas et al. · Hepatology · 2016 · 101 citations · Full text

Medicine, Biochemistry, Endocrinology +17

Plant lectins are novel Toll-like receptor agonists

John Unitt, David C. Hornigold · Biochemical Pharmacology · 2011 · 83 citations · Full text

Life Sciences, Botany, Immunology +14